Use of fucoidan in the preparation of compositions for the prevention and / or relief of cystitis.

TWI942646BActive Publication Date: 2026-10-11CHUNG SHAN MEDICAL UNIVERSITY
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
TW115103209
Authority / Receiving Office
TW · TW
Patent Type
Patents
Current Assignee / Owner
Filing Date
2026-01-27
Publication Date
2026-10-11
Estimated Expiration
2046-01-26

Smart Images

  • Figure TWG2TB001915895_001
    Figure TWG2TB001915895_001
  • Figure TWG2TB001915895_002
    Figure TWG2TB001915895_002
  • Figure TWG2TB001915895_003
    Figure TWG2TB001915895_003
Patent Text Reader

Abstract

Use of fucoidan in the preparation of a composition for the prevention and / or relief of cystitis, the composition containing an effective amount of fucoidan, wherein the fucoidan is a natural component and has not caused biotoxicity in cell and animal studies, wherein when the composition is administered to an individual, the fucoidan inhibits the expression of the NLRP3 inflammasome protein in the individual, and the fucoidan prevents and relieves the cystitis symptoms caused by the individual, wherein the cystitis is interstitial cystitis.
Need to check novelty before this filing date? Find Prior Art

Claims

1. Use of fucoidan in the preparation of a composition for the prevention and / or relief of cystitis, the composition containing an effective amount of fucoidan, the composition being administered to an individual, the fucoidan inhibiting the expression of the NLRP3 inflammasome protein in the individual, and the fucoidan preventing and relieving cystitis symptoms in the individual, wherein the cystitis is interstitial cystitis, the composition being administered to the individual orally, the effective amount of fucoidan being between 100 and 300 mg / kg based on the individual's weight, and the concentration of the fucoidan being between 1 and 5 μg / mL.

Citation Information

Patent Citations

  • Use of composition containing fucoxanthin and oligo-fucoidan for preparing pharmaceutical product treating or improving chronic kidney disease, composition containing fucoxanthin, oligo- fucoidan and L-carnitine, and pharmaceutical product containing the same effectively treating or slowing down the chronic kidney disease

    TW202327566A

  • Compositions and Methods for the Treatment of Inflammation in Urological Pathology

    US20230277559A1